← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Ubivac, Llc
Portland, OR
$3,816,444
Total funding
3
Grants
Funding over time
peak $880.6K · FY2006–14$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$3,816,444 · 3
By mechanism
R44$3,375,529 · 1
U43$288,718 · 1
R43$152,197 · 1
Investigators at Ubivac, Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
New Cancer Vaccine Technology Based on DRibbles Produced by Tumor Cells$760,163
R44 · FY2009 · CA
New Cancer Vaccine Technology Based on DRibbles Produced by Tumor Cells$685,832
R44 · FY2010 · CA
New Cancer Vaccine Technology Based on DRibbles Produced by Tumor Cells$672,271
R44 · FY2011 · CA
New Cancer Vaccine Technology Based on DRibbles Produced by Tumor Cells$648,309
R44 · FY2012 · CA
New Cancer Vaccine Technology Based on DRibbles Produced by Tumor Cells$608,954
R44 · FY2013 · CA
Aluminum Oxide Nanoparticles Conjugated to Antigens Potently Induce Tumor Specifi$271,683
U43 · FY2013 · CA
New Cancer Vaccine Technology Based on DRibbles Produced by Tumor Cells$152,197
R43 · FY2006 · CA
Aluminum Oxide Nanoparticles Conjugated to Antigens Potently Induce Tumor Specifi$17,035
U43 · FY2014 · CA